---
title: "Shandong Xinhua Pharmaceutical Gets China Approval for Prednisolone Acetate Raw Material"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/267773547.md"
description: "Shandong Xinhua Pharmaceutical Gets China Approval for Prednisolone Acetate Raw Material"
datetime: "2025-11-28T05:55:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/267773547.md)
  - [en](https://longbridge.com/en/news/267773547.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/267773547.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/267773547.md) | [繁體中文](https://longbridge.com/zh-HK/news/267773547.md)


# Shandong Xinhua Pharmaceutical Gets China Approval for Prednisolone Acetate Raw Material



### 相关股票

- [Xinhua Pharm (000756.CN)](https://longbridge.com/zh-CN/quote/000756.CN.md)
- [SHANDONG XINHUA (00719.HK)](https://longbridge.com/zh-CN/quote/00719.HK.md)

## 相关资讯与研究

- [Questions raised over Kenyan prince’s forex profits after hedge fund trader review](https://longbridge.com/zh-CN/news/279213871.md)
- [OSL Substantial Shareholder Liu Shuai Lifts Stake to Nearly 29%](https://longbridge.com/zh-CN/news/279171432.md)
- [Capital Group trims stake in Standard Chartered below 5%](https://longbridge.com/zh-CN/news/278822422.md)
- [Muyuan Foods Schedules Board Meeting to Approve 2025 Annual Results and Consider Dividend](https://longbridge.com/zh-CN/news/279065554.md)
- [Pathos CEO Increases Stake to Over 72% with Share Purchase](https://longbridge.com/zh-CN/news/279279933.md)